Urgent

Zollinger-Ellison syndrome

Peptic · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Gastrin-secreting neuroendocrine tumour (gastrinoma) causing severe acid hypersecretion with refractory/multiple peptic ulcers, diarrhoea and possible MEN1 association.

Red flags

  • GI bleeding/perforation from ulcers
  • Refractory ulcers despite standard therapy
  • Diarrhoea with dehydration
  • Features of MEN1

Assessment

Differential diagnosis

  • H. pylori peptic ulcer disease
  • NSAID-induced ulcers
  • Crohn disease
  • Idiopathic hyperacidity
  • Refractory GORD

Investigations

  • Fasting serum gastrin (off PPI where safe)
  • Gastric pH/acid studies, secretin stimulation test
  • Upper GI endoscopy (multiple/atypical ulcers)
  • Chromogranin A, calcium/PTH (MEN1 screen)
  • Somatostatin receptor imaging/CT for tumour localisation

Management

  • Treat acute complications (bleeding/perforation) as usual
  • High-dose proton pump inhibitor to control acid hypersecretion
  • Confirm diagnosis with gastrin and provocative testing
  • Screen for MEN1 (parathyroid, pituitary)
  • Localise and stage the tumour
  • Refer for surgical resection or somatostatin analogue therapy

Drugs & doses

High-dose proton pump inhibitor
Somatostatin analogue (octreotide/lanreotide)
Correct coexisting complications
Treat MEN1 components as needed

Disposition

Admit for complications; specialist endocrine/GI referral.

Complications & pitfalls

  • Ulcer bleeding/perforation
  • Metastatic gastrinoma
  • Severe diarrhoea/malabsorption

Exam pearls

  • Suspect with multiple or distal (jejunal) or recurrent ulcers
  • PPIs raise gastrin - interpret levels with caution
  • Up to a quarter of cases are part of MEN1

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.